AA
Andrew D. Ashe
See Remarks

Andrew D. Ashe insider trades: Verve Therapeutics (VERV) stock buys and sales

See Remarks, Verve Therapeutics Last trade Apr 2, 2025 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2013
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Andrew reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 2, 2025VERV↓ Sell$11K
May 14, 2024VERV↑ Buy$476K
Dec 2, 2021VERV↑ Buy$128K
Aug 3, 2015DYAX↓ Sell$1.5M
Mar 6, 2015DYAX↓ Sell$37K
Feb 26, 2015DYAX↓ Sell$23K
Mar 3, 2014DYAX↓ Sell$300K
Feb 26, 2014DYAX↓ Sell$28K
Aug 13, 2013DYAX↓ Sell$140K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Andrew D. Ashe's insider trades

Andrew D. Ashe is See Remarks at Verve Therapeutics (VERV). Since Aug 13, 2013, Andrew has reported 2 open-market purchases worth $604K and 7 sales worth $2.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (9 filings), option exercises (6 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VERV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.